eISSN 2508-3589
pISSN 2508-1926

Table. 2.

Table. 2.

Comparison of clinical characteristic between the non-EIFL and EIFL Groups

Group 1 (non-EIFL Group) (n = 27) Group 2 (EIFL Group) (n = 21)


Baseline End of follow-up p-value * Baseline End of follow-up p-value *
BCVA (logMAR) 0.14 ± 0.16 0.15 ± 0.14 0.416 0.18 ± 0.18 0.24 ± 0.19 0.020
CFT (μm) 336 ± 56.76 361 ± 41.59 0.088 411.38 ± 38.10 423.90 ± 46.86 0.093
ELM disruption 0 2 (7) 0.157 2 (9) 3 (14) 0.217
ELM disrupted length (μm) 0 181.0 ± 116.89 0.098 124.00 ± 112.50 187.33 ± 191.63 0.083
IS/OS disruption 5/27 (19) 8 (30) 0.317 5 (24) 9 (43) 0.056
IS/OS disrupted length (μm) 147.20 ± 178.40 222.37 ± 247.62 0.072 142.20 ± 216.87 289.33 ± 254.41 0.048
EIFL thickness (μm) - - - 74.61 ± 31.88 104.42 ± 45.65 0.040
Cotton ball sign 2 (7) 3 (11) 0.147 0 1 (5) 0.317

Values are presented as mean ± standard deviation or number (%).

EIFL = ectopic inner foveal layer; BCVA = best corrected visual acuity; logMAR = logarithm of minimal angle of resolution; CFT = central foveal thickness; ELM = external limiting membrane; IS/OS = photoreceptor inner segment/outer segment.

* Wilcoxon signed rank test.

J Retin 2020;5:128-34 https://doi.org/10.21561/jor.2020.5.2.128
© 2020 J Retin